4.6 Review

The metabolic syndrome, diabetes and lung dysfunction

期刊

DIABETES & METABOLISM
卷 34, 期 5, 页码 447-454

出版社

MASSON EDITEUR
DOI: 10.1016/j.diabet.2008.08.001

关键词

Metabolic syndrome; Diabetes mellitus; Lung dysfunction; Obstructive sleep apnoea (OSA); Chronic obstructive pulmonary disease (COPD); Endothelial progenitor cells (EPC); Review

向作者/读者索取更多资源

Sleep-disordered breathing and sleep apnoea are conditions frequently associated with comorbidity, including obesity, diabetes, hypertension, insulin resistance (metabolic syndrome) and cardiovascular disease. The diabetic state (type 1 and type 2 diabetes) may be associated to diminished lung function and, in particular, decreased vital capacity, and the association between chronic obstructive pulmonary disease (COPD) and type 2 diabetes may be due to a shared inflammatory process. Also, the alteration in circulating endothelial progenitor cells found in respiratory disease, the metabolic syndrome and cardiovascular disease reflect a common condition of endothelial dysfunction. (C) 2008 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

Clinical efficacy and safety of angiogenesis inhibitors: sex differences and current challenges

Andrea Cignarella, Gian Paolo Fadini, Chiara Bolego, Lucia Trevisi, Carlotta Boscaro, Viola Sanga, Teresa Maria Seccia, Antonio Rosato, Gian Paolo Rossi, Matthias Barton

Summary: This review discusses the challenges clinicians face in angiogenesis inhibitor therapy, including the need to consider sex differences in clinical efficacy and safety, and proposes future research directions.

CARDIOVASCULAR RESEARCH (2022)

Article Biochemistry & Molecular Biology

Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes

Mattia Albiero, Marianna D'Anna, Benedetta Maria Bonora, Gaia Zuccolotto, Antonio Rosato, Marco Giorgio, Elisabetta Iori, Angelo Avogaro, Gian Paolo Fadini

Summary: For the first time, this study explores the hematopoietic and nonhematopoietic roles of p66Shc in regulating HSPC traffic and ischemic responses. Hematopoietic deletion of p66Shc is sufficient to rescue HSPC mobilization and homing in diabetes after ischemia and improves blood flow recovery. Inhibiting p66Shc in blood cells may be a novel strategy to counter PAD in diabetes.

ANTIOXIDANTS & REDOX SIGNALING (2022)

Review Endocrinology & Metabolism

Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors

Gian Paolo Fadini, Stefano Del Prato, Angelo Avogaro, Anna Solini

Summary: With the increasing global population aging and prevalence of type 2 diabetes, prevention of diabetic complications remains a major challenge. SGLT2 inhibitors have been proven to reduce DKD progression and improve cardiovascular outcomes, but critical challenges such as channelling bias and database heterogeneity need to be addressed in research studies.

DIABETES OBESITY & METABOLISM (2022)

Article Endocrinology & Metabolism

Glycemic control after switching to faster aspart in adults with type 1 diabetes

G. P. Fadini, F. Boscari, D. Falaguasta, S. Ferretto, A. Maran, A. Avogaro, D. Bruttomesso

Summary: In routine care, patients with type 1 diabetes who switched to faster insulin aspart (FIA) experienced a reduction in the time spent in hyperglycemia > 250 mg/dl during daytime and an increase in time in range. These improvements were particularly significant for patients with higher baseline HbA1c levels.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Editorial Material Endocrinology & Metabolism

Perturbation of Glucose Homeostasis During Acute Illness: Stress Hyperglycemia and Relative Hypoglycemia

Gian Paolo Fadini

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice

Mattia Albiero, Stefano Ciciliot, Anna Rodella, Ludovica Migliozzi, Francesco Ivan Amendolagine, Carlotta Boscaro, Gaia Zuccolotto, Antonio Rosato, Gian Paolo Fadini

Summary: Innate immune cells infiltrate and spread inflammatory signals in growing adipose tissue, leading to glucose intolerance and insulin resistance in distant tissues. Oncostatin M (OSM), a cytokine, is debated for its role in the metabolic consequences of overfeeding. Through this study, it was found that OSM is required during obesity development, as its concentrations are dynamically regulated during a high-fat diet. Osm(-/-) mice showed glucose intolerance, impaired muscle glucose uptake, and worsened liver inflammation and damage, demonstrating the importance of OSM in adapting to overfeeding.

DIABETES (2023)

Article Endocrinology & Metabolism

Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes

Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Didac Mauricio, Angelo Avogaro, Giulio Ceolotto, Saula Vigili de Kreutzenberg

Summary: This study analyzed the miRNA expression profile in patients with type 1 diabetes who had either carotid calcified or fibrous plaque. The results showed that miR-503-5p, let-7d-5p, miR-106b-3p, and miR-93-5p were significantly upregulated in patients with calcified plaque, while miR-10a-5p was downregulated. These findings provide new insights into the pathophysiology of plaque formation.

DIABETES CARE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Deciphering dementia in the cardiometabolic continuum

Gian Paolo Fadini, Mario Luca Morieri

EUROPEAN HEART JOURNAL (2023)

Article Endocrinology & Metabolism

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

M. L. Morieri, I. Raz, A. Consoli, M. Rigato, A. Lapolla, F. Broglio, E. Bonora, A. Avogaro, G. P. Fadini

Summary: This study compared the effectiveness of dapagliflozin to DPP-4 inhibitors in achieving individualized HbA1c targets and extra-glycaemic endpoints in elderly patients with type 2 diabetes. The results showed that patients initiating dapagliflozin had a lower likelihood of reaching individualized HbA1c targets compared to those initiating DPP-4 inhibitors. However, they experienced greater improvements in body weight and blood pressure.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features

B. M. Bonora, R. Cappellari, M. Albiero, L. Prevedello, M. Foletto, R. Vettor, A. Avogaro, G. P. Fadini

Summary: This study examined adipose tissue-derived stem cells (ASCs) in individuals with metabolic syndrome traits and found that these cells can enter the systemic circulation and establish ectopic adipose depots, leading to insulin resistance. This phenomenon, previously observed in mice, has been confirmed in humans, highlighting the importance of further investigation.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Endocrinology & Metabolism

Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials

Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro

Summary: This study aimed to assess the safety of SGLT2 inhibitors (SGLT2is) in elderly patients with type 2 diabetes. A meta-analysis of randomized controlled trials (RCTs) showed that SGLT2is were well tolerated in the elderly, but older patients were underrepresented in clinical trials.

DIABETES OBESITY & METABOLISM (2023)

Review Endocrinology & Metabolism

Recent developments in targets for ischemic foot disease

Jonathan Golledge, Shivshankar Thanigaimani, Kristen S. Barratt, Gian Paolo Fadini

Summary: Diabetes is a major risk factor for ischaemic foot disease, which can lead to severe complications such as tissue loss and amputation. Current treatment options focus on revascularisation, but there are limitations in both surgical eligibility and success rates. Recent research in animal models and clinical trials have identified potential novel medical targets for ischaemia, aiming to improve wound healing and enhance blood supply recovery. However, translating these findings to human patients remains challenging due to limitations in clinically relevant animal models. Promising results have been reported in small clinical trials with certain therapies, but further research and larger clinical trials are needed to determine their broader applicability.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro, Gian Paolo Fadini

Summary: This study aimed to investigate whether measuring circulating levels of haematopoietic stem/progenitor cells (HSPCs) can improve the prediction of long-term kidney outcomes in individuals with type 2 diabetes. The results showed that HSPC levels are associated with worsening kidney function and can enhance the identification of adverse kidney outcomes in individuals with type 2 diabetes.

DIABETOLOGIA (2023)

暂无数据